The use of cardiopulmonary bypass in pediatric cardiac surgery is associated with significant inflammation, fluid overload, and end-organ dysfunction yielding morbidity and mortality. For decades, various intraoperative ultrafiltration techniques such as conventional ultrafiltration, modified ultrafiltration (MUF), zero-balance ultrafiltration (ZBUF), and combination techniques (ZBUF-MUF) have been used to mitigate these toxicities and promote improved postoperative outcomes. However, there is currently no consensus on the ultrafiltration technique or strategy that yields the most benefit for infants and children undergoing open heart surgery.
Methods:
A librarian-conducted PubMed literature search from 1990 to 2018 yielded 90 clinical studies or publications on the various forms of ultrafiltration and the impact on physiologic markers and clinical outcomes. All publications were reviewed, summarized, and conclusions synthesized. The data sets were not combined for systematic or meta-analysis due to significant heterogeneity in study protocols and patient populations.
Results:
Modified ultrafiltration significantly promotes improved myocardial function, reduction in fluid overload, and reduced bleeding and transfusion complications. Furthermore, ZBUF has shown a consistent reduction in inflammatory cytokines and improved pulmonary function and compliance. There is conflicting evidence that MUF, ZBUF, and ZBUF-MUF culminate in reduced ventilation time and intensive care unit stay.
Conclusion:
Various modes of ultrafiltration have been shown to be associated with improved physiologic function or clinical outcomes in pediatric cardiac surgery. There are some inconsistent trial results that can be explained by heterogeneity in ultrafiltration, clinical staff preferences, and institution protocols. Ultrafiltration has some essential benefit as it is ubiquitously used at pediatric heart centers; however, the optimal protocol could be yet identified.
NaikSKKnightAElliottMJ. A successful modification of ultrafiltration for cardiopulmonary bypass in children. Perfusion. 1991;6(1):41–50.
2.
ButlerJRockerGMWestabyS. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55(2):552–559.
3.
NaikSKnightA. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation. 1991;84(suppl 5):III422–III431.
4.
WangMJChiuISHsuCM, et al.Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations. Ann Thorac Surg. 1996;61(2):651–656.
5.
ElliotM. Modified ultrafiltration and open heart surgery in children. Paediatr Anaesth. 1999;9(1):1–5.
6.
JournoisDIsrael-BietDPouardP, et al.High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology. 1996;85(5):965–976.
7.
TallmannRDDumondMBrownD. Inflammatory mediator removal by zero-balance ultrafiltration during cardiopulmonary bypass. Perfusion. 2002;17(2):111–115.
HuangHYaoTWangW, et al.Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg. 2003;76(1):136–140.
10.
LiuJJiBLongCLiCFengZ. Comparative effectiveness of methylprednisolone and zero-balance ultrafiltration on inflammatory response after pediatric cardiopulmonary bypass. Artif Organs. 2007;31(7):571–575.
JaggersJLawsonJH. Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies. Ann Thorac Surg. 2006;81(6):2360–2366.
13.
KernFHMoranaNJSearsJJHickeyPR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg. 1992;54:541–546.
14.
FriesenRHCampbellDNClarkeDRTornabeneMA. Modified ultrafiltration attenuates dilutional coagulopathy in pediatric open heart operations. Ann Thorac Surg. 1997;64(6):1787–1789.
15.
ChaturvediRRShoreDFWhitePA, et al.Modified ultrafiltration improves global left ventricular systolic function after open-heart surgery in infants and children. Eur J Cardiothorac Surg. 1999;15(6):742–746.
16.
OotakiYYamaguchiMOshimaY, et al.Effects of modified ultrafiltration on coagulation factors in pediatric cardiac surgery. Surg Today. 2002;32(3):203–206.
17.
WangWHuangHMZhuDMChenHSuZKDingWX. Modified ultrafiltration in pediatric cardiopulmonary bypass. Perfusion. 1998;13(5):304–310.
18.
WangWZhuDMHuangHM, et al.Effect of flow rate, negative pressure, and duration of modified ultrafiltration on hemodynamics and inflammatory mediators. ASAIO J. 2007;53(1):41–45.
19.
SchlünzenLPedersenJHjortholmKHansenOKDitlevsenE. Modified ultrafiltration in paediatric cardiac surgery. Perfusion. 1998;13(2):105–109.
20.
GaynorJWKuypersMvan RossemM, et al.Haemodynamic changes during modified ultrafiltration immediately following the first stage of the Norwood reconstruction. Cardiol Young. 2005;15(1):4–7.
21.
KeenanHTThiagarajanRStephensKEWilliamsGRamamoorthyCLupinettiFM. Pulmonary function after modified venovenous ultrafiltration in infants: a prospective, randomized trial. J Thorac Cardiovasc Surg. 2000;119(3):501–507.
22.
HonjoOOsakiSKotaniYAkagiTSanoS. Diagnosis-based differences in response of global ventricular performance to modified ultrafiltration in children. Circ J. 2010;74(1):86–92.
23.
JiaZTengYLiuYWangHLiYHouX. Influence of high-flow modified ultrafiltration on brain oxygenation and perfusion during surgery for children with ventricular septal defects: a pilot study. Perfus (United Kingdom). 2018;33(3):203–208.
24.
DraaismaAMHazekampMGFrankMAnesNSchoofPHHuysmansHA. Modified ultrafiltration after cardiopulmonary bypass in pediatric cardiac surgery. Ann Thorac Surg. 1997;64(2):521–525.
25.
RodriguezRARuelMBroeckerLCornelG. High flow rates during modified ultrafiltration decrease cerebral blood flow velocity and venous oxygen saturation in infants. Ann Thorac Surg. 2005;80(1):22–28.
26.
TürközATunçayEBalciŞT, et al.The effect of modified ultrafiltration duration on pulmonary functions and hemodynamics in newborns and infants following arterial switch operation. Pediatr Crit Care Med. 2014;15(7):600–607.
27.
McRobbCMIngRJLawsonDSJaggersJTwiteM. Retrospective analysis of eliminating modified ultrafiltration after pediatric cardiopulmonary bypass. Perfus (United Kingdom). 2017;32(2):97–109.
28.
AdNSnirEKatzJBirkEVidneBA. Use of the modified technique of ultrafiltration in pediatric open-heart surgery: a prospective study. Isr J Med Sci. 1996;32(12):1326–1331.
29.
KameyamaTAndoFOkamotoF, et al.The effect of modified ultrafiltration in pediatric open heart surgery. Ann Thorac Cardiovasc Surg. 2000;6(1):19–26.
30.
KoutlasTCGaynorJWNicolsonSCStevenJMWernovskyGSprayTL. Morbidity after cavopulmonary connection. Ann Thorac Sur. 1997;4975(97):37–43.
31.
ChewMSBrix-ChristensenVRavnHB, et al.Effect of modified ultrafiltration on the inflammatory response in paediatric open-heart surgery: a prospective, randomized study. Perfusion. 2002;17(5):327–333.
32.
KotaniYHonjoOOsakiS, et al.Effect of modified ultrafiltration on postoperative course in neonates with complete transposition of the great arteries undergoing arterial switch operation. Circ J. 2008;72(9):1476–1480.
33.
BandoKTurrentineMWVijayP, et al.Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease. Ann Thorac Surg. 1998;66(3):821–827; discussion 828.
34.
WilliamsGDRamamoorthyCChuL, et al.Modified and conventional ultrafiltration during pediatric cardiac surgery: clinical outcomes compared. J Thorac Cardiovasc Surg. 2006;132(6):1291–1298.
35.
MilovanovicVBisenicDMimicB, et al.Reevaluating the importance of modified ultrafiltration in contemporary pediatric cardiac surgery. J Clin Med. 2018;7(12):1–13.
36.
UngerleiderRM. Effects of cardiopulmonary bypass and use of modified ulftrafiltration. Ann Thorac Surg. 1998;65(6 suppl):35–39.
37.
GristGWhittakerCMerriganK, et al.The correlation of fluid balance changes during cardiopulmonary bypass to mortality in pediatric and congenital heart surgery patients. J Extra Corpor Technol. 2011;43(4):215–226.
38.
MahmoudASBurhaniMSHannefAA, et al.Effect of modified ultrafiltration on pulmonary function after cardiopulmonary bypass. Chest. 2005;128(5):3447–3453.
39.
MalufMA. Modified ultrafiltration in surgical correction of congenital heart disease with cardiopulmonary bypass. Perfusion. 2003;18(suppl 1):61–68.
40.
HiramatsuTImaiYKurosawaH, et al.Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the Fontan procedure. Ann Thorac Surg. 2002;73(3):862–865.
41.
PearlJMManningPBMcNamaraJLSaucierMMThomasDW. Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, endothelin-1 in infants undergoing cardiopulmonary bypass. Ann Thorac Surg. 1999;68(4):1369–1375.
42.
MingZDWeiWHongCWeiZXiangDW. Balanced ultrafiltration, modified ultrafiltration, and balanced ultrafiltration with modified ultrafiltration in pediatric cardiopulmonary bypass. J Extra Corpor Technol. 2001;33(4):223–226.
43.
RicciZPolitoANettoR, et al.Assessment of modified ultrafiltration hemodynamic impact by pressure recording analytical method during pediatric cardiac surgery. Pediatr Crit Care Med. 2013;14(4):390–395.
44.
ZiyaeifardMAlizadehaslAMassoumiG. Modified ultrafiltration during cardiopulmonary bypass and postoperative course of pediatric cardiac surgery. Res Cardiovasc Med. 2014;3(2):e17830. doi:10.5812/cardiovascmed.
45.
SaatvedtKLindbergHGeiranOR, et al.Ultrafiltration after cardiopulmonary bypass in children: effects on hemodynamics, cytokines and complement. Cardiovasc Res. 1996;31(4):596–602.
46.
DaviesMNguyenKGaynorJElliottM. Modified ultrafiltration improves left ventricular systolic function in infants after cardiopulmonary bypass. J Thorac. 1997;115(2):361–370.
47.
ZiyaeifardMAlizadehaslAAghdaiiN, et al.The effect of combined conventional and modified ultrafiltration on mechanical ventilation and hemodynamic changes in congenital heart surgery. J Res Med Sci. 2016;21(8):1–7.
48.
ThompsonLNDMcElhinneyDBFindlayP, et al.A prospective randomized study comparing volume-standardized modified and conventional ultrafiltration in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2001;122(2):220–228.
49.
BandoKVijayPTurrentineMW, et al.Dilutional and modified ultrafiltration reduces pulmonary hypertension after operations for congenital heart disease: a prospective randomized study. J Thorac Cardiovasc Surg. 1998;115(3):517–527.
50.
PaparellaDYauTMYoungE. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21(2):232–244.
51.
BronickiRAHallM.Cardiopulmonary bypass-induced inflammatory response: pathophysiology and treatment. Pediatr Crit Care Med. 2016;17(8):S272–S278. doi:10.1097/PCC.0000000000000759.
52.
ShenIGiacomuzziCUngerleiderRM. Current strategies for optimizing the use of cardiopulmonary bypass in neonates and infants. Ann Thorac Surg. 2003;75(2):S729–734.
53.
SeverKTanselTBusaranM, et al.The benefits of continuous ultrafiltration in pediatric cardiac surgery. Scand Cardiovasc J. 2004;38(5):307–311.
54.
AndreassonSGöthbergSBerggrenHBengtssonAErikssonERisbergB. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg. 1993;56(6):1515–1517.
55.
YndgaardSAndersenLWAndersenCPettersonGBaekL. The effect of modified ultrafiltration on the amount of circulating endotoxins in children undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14(4):399–401.
56.
ChewMS. Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass?Perfusion. 2004;19:S57–S60.
57.
PalladinoMABahjatFRTheodorakisEAMoldawerLL. Anti-TNF-α therapies: the next generation. Nat Rev Drug Discov. 2003;2(9):736–746.
58.
WatanabeNKobayashiY. Selective release of a processed form of interleukin 1α. Cytokine. 1994;6(6):597–601.
59.
BratDJBellailACVan MeirWG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005;7(2):122–133.
60.
ZhouW. The new face of anaphylatoxins in immune regulation. Immunobiology. 2012;217(2):225–234.
61.
RiveraESKimballTRBaileyWWWittSAKhouryPRDanielsSR. Effect of veno-venous ultrafiltration on myocardial performance immediately after cardiac surgery in children. A prospective randomized study. J Am Coll Cardiol. 1998;32(3):766–772.
62.
GaynorJW. Use of ultrafiltration during and after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg. 2001;122(2):209–211.
63.
TakabayashiSShimpoHYokoyamaKIwataH. Relationship between increased blood pressure and hematocrit during modified ultrafiltration for pediatric open heart surgery. Gen Thorac Cardiovasc Surg. 2007;55(1):12–18.
64.
HarveyBShannKGFitzgeraldD, et al.International pediatric perfusion practice: 2011 survey results. J Extra Corpor Technol. 2012;44(4):186–193.
